Curasite® is Izun’s topical gel for the management of diabetic foot ulcers, pressure sores, and other non-healing chronic wounds.
Multiple clinical studies have demonstrated rapid and profound healing in wounds that have been nonresponsive to treatments for up to two years. The studies demonstrated over 50% wound healing within 1 month of treatment and over 80% within 3 months.
FDA approval was received March 2017 with multiple claims including “indicated for first-line therapy” in wound care.
Izun is currently in negotiations with multiple licensing partners.
Market size estimated at $1.6B.